selected publications
-
Journal Article
- Effects of TZD use and discontinuation on fracture rates in ACCORD Bone Study. Journal of Clinical Endocrinology and Metabolism. 2015
- Durable change in glycaemic control following intensive management of type 2 diabetes in the ACCORD clinical trial. Diabetologia. 2014
- Intensive blood pressure control, falls, and fractures in patients with type 2 diabetes: the ACCORD Trial. Journal of General Internal Medicine. 2014
- Paradoxical reduction in HDL-C with fenofibrate and thiazolidinedione therapy in type 2 diabetes: the ACCORD Lipid Trial. Diabetes care. 2014
- Depression predicts all-cause mortality: epidemiological evaluation from the ACCORD HRQL substudy. Diabetes care. 2012
- Diabetes symptoms and distress in ACCORD trial participants: relationship to baseline clinical variables. Clinical Diabetes. 2012
- Effect of intensive versus standard blood pressure control on depression and health-related quality of life in type 2 diabetes: The ACCORD trial. Diabetes care. 2012
- Effect of intensive versus standard blood pressure control on depression and health-related quality of life in type 2 diabetes: the ACCORD trial. Diabetes care. 2012
- Glycaemia and correlates of patient-reported outcomes in ACCORD trial participants. Diabetic Medicine. 2012
- Intensive glycemic control is not associated with fractures or falls in the ACCORD randomized trial. Diabetes care. 2012
- Long-term effects of incident diabetes mellitus on cardiovascular outcomes in people treated for hypertension: the ALLHAT Diabetes Extension Study. Circulation: Cardiovascular Quality and Outcomes. 2012
- Effect of intensive glycemic lowering on health-related quality of life in type 2 diabetes: ACCORD trial. Diabetes care. 2011
- Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet (London, England). 2010
-
Conference Paper
-
Abstract